ICTUImperial Clinical Trials Unit

Welcome to Imperial Clinical Trials Unit (ICTU)

This website is intended for commercial trial sponsors engaged in the area of pharmaceuticals, medical devices or diagnostic devices

Clinical Trials Search

OR

CurrentAll Trials

NITRATE-OCT

Trial Details

  • Trial statusRecruiting
  • Chief InvestigatorAmrita Ahluwalia
  • Project managerKrishnaraj Rathod
  • SponsorQMUL
  • ISRCTN number17373946
  • Phase2

A randomised, double-blind, placebo-controlled study investigating the effects of dietary nitrate on vascular function, platelet reactivity and restenosis in stable angina

Design and Objective

This is a prospective double-blind, placebo controlled, cross-over, clinical study. The trial is designed to test whether dietary nitrate ingestion in addition to conventional therapy has beneficial effects in patients with stable angina.

Key inclusion criteria

1. Patients with stable angina diagnosed by a cardiologist on optimal medical therapy undergoing angioplasty to treat residual symptoms. 2. Aged 18-85 3. Patients able and willing to give their written informed consent. 4. Patients undergoing successful PCI procedure.

Study Disclaimer Statement